Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of Use of a Customized Acoustic Stimulus to Reduce the Disturbing Symptoms of Tinnitus and Hyperacusis

NCT00730834 is registered in ClinicalTrials.gov with Neuromonics, Inc. as lead sponsor.

NCT NCT00730834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00730834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of Use of a Customized Acoustic Stimulus to Reduce the Disturbing Symptoms of Tinnitus and Hyperacusis
Lead sponsor
Neuromonics, Inc.
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2007
Completion date
December 31, 2010
Enrollment
53 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperacusis, tinnitus